BioPharma Credit PLC Director/PDMR Shareholding (7847X)

TIDMBPCR

RNS Number : 7847X

BioPharma Credit PLC

06 May 2021

BIOPHARMA CREDIT PLC

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 
 1.   Details of person discharging managerial responsibilities/person 
       closely associated with them 
 a)   Name                      Anita Hyman 
     ------------------------  -------------------------------------------- 
 2.   Reason for the notification 
     ---------------------------------------------------------------------- 
 a)   Position / status         Person Closely Associated with Harry 
                                 Hyman (Director of BioPharma Credit PLC) 
     ------------------------  -------------------------------------------- 
 b)   Initial notification      Initial notification 
       / amendment 
     ------------------------  -------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------------- 
 a)   Name                      BioPharma Credit PLC 
     ------------------------  -------------------------------------------- 
 b)   LEI                       213800AV55PYXAS7SY24 
     ------------------------  -------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------------- 
 a)   Description                 Ordinary Shares of $0.01 each 
       of the financial            GB00BDGKMY29 
       instrument 
       Identification 
       Code 
     --------------------------  ------------------------------------------ 
 b)   Nature of the               Purchase of Shares (acquired as part 
       transaction                 of dividend reinvestment) 
     --------------------------  ------------------------------------------ 
 c)   Price(s) and                 Price(s)       Volume(s) 
       volume(s)                    GBP0.699867    50 
                                                  ---------- 
     --------------------------  ------------------------------------------ 
 d)   Aggregated information      N/A 
       - Aggregated 
       volume 
       - Price 
     --------------------------  ------------------------------------------ 
 e)   Date of the                 05.05.21 
       transaction 
     --------------------------  ------------------------------------------ 
 f)   Place of the                London Stock Exchange (XLON) 
       transaction 
     --------------------------  ------------------------------------------ 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGCGDULBGDGBL

(END) Dow Jones Newswires

May 06, 2021 05:30 ET (09:30 GMT)